SBPLX
Price
$29.99
Change
-$0.22 (-0.73%)
Updated
Jun 13 closing price
Net Assets
8.54B
VIVAX
Price
$67.64
Change
-$0.55 (-0.81%)
Updated
Jun 13 closing price
Net Assets
188.77B
Interact to see
Advertisement

SBPLX vs VIVAX

Header iconSBPLX vs VIVAX Comparison
Open Charts SBPLX vs VIVAXBanner chart's image
ClearBridge Dividend Strategy C
Price$29.99
Change-$0.22 (-0.73%)
VolumeN/A
Net Assets8.54B
Vanguard Value Index I
Price$67.64
Change-$0.55 (-0.81%)
VolumeN/A
Net Assets188.77B
SBPLX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SBPLX vs. VIVAX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBPLX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. SBPLX (8.54B). VIVAX pays higher dividends than SBPLX: VIVAX (2.16) vs SBPLX (0.48). SBPLX was incepted earlier than VIVAX: SBPLX (27 years) vs VIVAX (33 years). SBPLX (1.74) is less costly to investors than VIVAX (0.17). SBPLX is a more actively managed with annual turnover of: 19.00 vs. VIVAX (9.00). SBPLX has a lower initial minimum investment than VIVAX: SBPLX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.88 vs. SBPLX (4.53). VIVAX return over 5 years is better than : 73.96 vs. SBPLX (38.23).
SBPLXVIVAXSBPLX / VIVAX
Total Expense Ratio1.740.171,024%
Annual Report Gross Expense Ratio1.740.171,024%
Fund Existence27 years33 years-
Gain YTD4.2123.252130%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets8.54B189B5%
Annual Yield % from dividends0.482.1622%
Returns for 1 year4.538.8851%
Returns for 3 years18.1933.2755%
Returns for 5 years38.2373.9652%
Returns for 10 years60.31105.2057%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSUTX61.72N/A
N/A
Goldman Sachs US Equity Insights Inv
DVLIX30.71N/A
N/A
BNY Mellon Opportunistic Midcap Value I
MNCSX12.36N/A
N/A
Mercer Non-US Core Equity I
AFMFX58.08-0.45
-0.77%
American Funds American Mutual F3
BRKAX15.38-0.21
-1.35%
MFS Blended Research Em Mkts Eq A